Eight-point Reliable Change on Symbol Digit Modalities Test with Ozanimod: Findings from the Phase 3 SUNBEAM and DAYBREAK Extension Trials (P6-6.015)
Year: 2024
Type: article
Source: Neurology
Authors: John DeLuca, Jeffrey Cohen, Bruce Cree, Giancarlo Comi, Ludwig Kappos, Chun-Yen Cheng, James Sheffield, Jon Riolo, Andrew Thorpe, Ralph Benedict
Institutions: Kessler Foundation, Rutgers New Jersey Medical School, Cleveland Clinic, University of California, San Francisco, Vita-Salute San Raffaele University, University of Basel, University Hospital of Basel, Bristol-Myers Squibb (United States), University at Buffalo, State University of New York
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4394600643